MINERAL IV Injection — Class I drug recall D-1563-2014
Terminated recall by Abrams Royal Pharamacy, reported 2014-09-03, distributed nationwide. Non-Sterility; analytical results found product to contain Sphingomonas paucimobilis
| Recall number | D-1563-2014 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Abrams Royal Pharamacy, Dallas, TX, United States |
| Recall initiated | 2013-12-19 |
| Classified | 2014-08-25 |
| Reported by FDA | 2014-09-03 |
| Terminated | 2016-10-07 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA |
| Quantity | 74 |
| Reason classes | sterility |
Product
MINERAL IV Injection, compounded by Abrams Royal Pharmacy, Inc., Dallas, TX
Reason for recall
Non-Sterility; analytical results found product to contain Sphingomonas paucimobilis
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1563-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.